论文部分内容阅读
Antihistamine agent Dimebon belongs to a fast-growing group of "old" drugs that were suggested to be effective for therapy of pathological conditions different from their original targets.The ability of dimebon to ameliorate progression of tauopathies has been tested in transgenic tauP301S mice.